Given the use of T cells for HDAC inhibitor therapies and the importance of HDAC activity in T cell responses to immune and infectious diseases (Akimova et al, 2012), we sought to characterize HDAC interactions in this cell type. This evidence concerns the gene HDAC9 and infectious disease.